Related Experiment Video
Updated: Jan 16, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Factors Related to Suboptimal Adherence to Dyslipidemia Medication: An Exploration Using Nationally Representative
Jihye Shin1, Taegyu Um1, Sangyong Jo2
1Department of Physiology, Dong-A University College of Medicine, Busan, Korea.
Suboptimal adherence to dyslipidemia medication affects 5.7% of patients, influenced by age, diagnosis duration, and comorbidities. Targeted interventions are crucial for effective lipid management.
Area of Science:
- Cardiology
- Public Health
- Pharmacoeconomics
Background:
- Dyslipidemia is a prevalent chronic condition with significant treatment challenges.
- Suboptimal medication adherence remains a persistent issue in managing dyslipidemia.
- Limited research exists on factors contributing to poor adherence in dyslipidemia treatment.
Purpose of the Study:
- To identify clinical variables associated with suboptimal adherence to dyslipidemia medications.
- To explore demographic and clinical factors influencing medication adherence.
- To understand patient-reported reasons for non-adherence.
Main Methods:
- Utilized data from the Korea National Health and Nutrition Examination Survey (2010-2021) and Korea Health Panel Survey (2018).
- Applied complex sampling analysis for national population representative estimates.
- Employed multivariable-adjusted logistic regression to identify factors associated with suboptimal adherence.
Main Results:
- 5.7% of the study population exhibited suboptimal adherence to dyslipidemia medications.
- Factors associated with reduced adherence included older age, longer duration since diagnosis, and comorbidities (hypertension, diabetes, ischemic heart disease, depression).
- Sex-specific differences were observed, with depression, ischemic heart disease, and elevated hemoglobin impacting adherence differently. Common reasons for non-adherence were forgetting, symptom improvement, and health risk concerns.
Conclusions:
- Identified key clinical factors and patient-reported reasons for suboptimal adherence in dyslipidemia treatment.
- Highlighted significant differences in adherence factors between sexes and across the general population.
- Emphasized the necessity for tailored interventions to improve adherence and optimize lipid management outcomes.
More Related Videos
03:05Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
Published on: November 21, 2025
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Factors Affecting Drug Distribution: Miscellaneous Factors
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...